Contraindications Sample Clauses

Contraindications. This is a general description of the disease or condition and the patient population for which the device should not be used for the purpose of diagnosing, treating, curing or mitigating. Contraindications are conditions under which the device should not be used because the risk of use clearly outweighs any possible benefit.
AutoNDA by SimpleDocs
Contraindications. Advanced arteriosclerosis; agitated states; hyperthyroidism; moderate hypertension; severe hypertension; symptomatic cardiovascular disease Adverse effects Common or Very Common Abdominal cramps, aggression, agitation, anxiety, constipation, decreased appetite, depression, diarrhea, dizziness, dry mouth, dyspnoea, growth restriction, headache, irritability, labile mood, nausea, palpitations, pyrexia, rash, restlessness, sleep disturbances, somnolence, tachycardia, tics, vomiting and weight loss Uncommon Agitation, bruxism, cardiomyopathy, chest pain, dermatillomania, dysgeusia, dyskinesia, dysphoria, euphoria, hallucinations, hypertension, logorrhea, mania, mydriasis, psychomotor hyperactivity, Raynaud’s Syndrome, sexual dysfunction, sweating, urticarial, visual disturbances Frequency not known Psychotic episodes and seizures. Drug interactions - Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx Lisdexamfetamine Shared Care Agreement I have read the Lisdexamfetamine Shared Care Agreement Please circle a response A) I am willing to prescribe Lisdexamfetamine and adhere to the terms in this Shared Care Agreement B) I am not willing to prescribe Lisdexamfetamine as per this Shared Care Agreement Name (Print)
Contraindications. General contraindications for coronary stenting and for the use of this device are: · Unprotected left main coronary artery disease; · Coronary artery spasm; · Lesions involving a bifurcation; · Cardiogenic shock; · Any patients judged to have a lesion which may prevent proper stent deployment; · Vessel trauma requiring surgical repair or reintervention · Total occlusion of target lesion · Ejection fraction <30%; · Allergies to required procedural medications; · Lesions involving arterial segments with highly tortuous anatomy; · Severe reaction to contrast agents; · Contraindication for anti-platelets and/or anti-coagulation therapy; · Known allergies to Stainless Steel or Polyethelyne Theraphalate. · Cardiac Tamponade · Emboli, distal (air, tissue or thrombotic emboli) · Emergent Coronary Artery Bypass Surgery (CABG) · Pericardial effusion · Pseudoaneurysm, femoral · Respiratory Failure · Shock/Pulmonary edema
Contraindications. Budenofalk® 2mg rectal foam must not be used in: - hypersensitivity to budesonide or any of the ingredients - hepatic cirrhosis with signs of portal hypertension, e.g. late-stage primary biliary cirrhosis
Contraindications. Advanced arteriosclerosis; agitated states; hyperthyroidism; moderate hypertension; severe hypertension; symptomatic cardiovascular disease Cautions Bipolar disorder; history of cardiovascular disease; history of substance abuse; may lower seizure threshold (discontinue if seizures occur); psychotic disorders; susceptibility to angle-closure glaucoma; tics; Tourette syndrome. Adverse effects Common or very common Abdominal cramps, aggression, agitation, anxiety, constipation, decreased appetite, depression, diarrhea, dizziness, dry mouth, dyspnoea, growth restriction, headache, irritability, labile mood, nausea, palpitations, pyrexia, rash, restlessness, sleep disturbances, somnolence, tachycardia, tics, vomiting and weight loss Uncommon Agitation, bruxism, cardiomyopathy, chest pain, dermatillomania, dysgeusia, dyskinesia, dysphoria, euphoria, hallucinations, hypertension, logorrhea, mania, mydriasis, psychomotor hyperactivity, Raynaud’s Syndrome, sexual dysfunction, sweating, urticarial, visual disturbances Frequency not known Psychotic episodes and seizures. For other adverse effects refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx, Drug interactions Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx,
Contraindications. Do not use Whole Body Cryotherapy if you have any of the following conditions: • Uncontrolled high blood pressure • Cold Allergy • Prior heart attack • Open sores • Unstable chest pain • Nerve pain in feet or legs • Disease of blood vessels • Pregnancy • History of blood clots You may have other conditions that make whole body cryotherapy inappropriate. Consult with your physician or medical advisor if you have questions as to whether whole body cryotherapy is right for you.
Contraindications. “In all paediatric patients (0-18 years of age) who undergo tonsillectomy and/or adenoidectomy for obstructive sleep apnoea syndrome due to an increased risk of developing serious and life-threatening adverse reactions (see section 4.4)” “In women during breastfeeding (see section 4.6)” “In patients for whom it is known they are CYP2D6 ultra-rapid metabolisers”
AutoNDA by SimpleDocs

Related to Contraindications

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Markings 2.8.1. Every hose shall bear, at intervals of not greater than 0.5 m, the following clearly legible and indelible identification markings consisting of characters, figures or symbols.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!